Accessibility Menu
Endo International Plc logo

Endo International Plc(OTC) ENDP

This security has been delisted. This page is retained for historical reference.

Endo International Plc last closing stock price
MetricPriceDate
Last closeUSD 0.002024-05-01
Endo International Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002024-04-24
1 month+50%USD 0.002024-04-01
3 month+0%USD 0.002024-02-01
Year to date+20%USD 0.002023-12-29
1 year-98.98%USD 0.062023-05-02
3 year-99.99%USD 5.732021-04-30
5 year-99.99%USD 8.202019-05-03
Since inception-100%USD 12.252000-07-18

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

ENDP Financials

Key Financial Metrics (TTM)

Gross Margin

59.21%

Operating Margin

0.53%

Net Income Margin

-19.01%

Return on Equity

60.16%

Return on Capital

0.23%

Return on Assets

-6.49%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.65B

Operating Income

-$1.86B

EBITDA

-$1.25B

Operating Cash Flow

$368.53M

Capital Expenditure

-$108.74M

Free Cash Flow

$259.79M

Cash & ST Invst.

$1.19B

Total Debt

$8.11B

Endo International Plc Performance Analysis

Endo International Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 2,993,206,000N/A
20222022-12-31USD 2,318,875,000-22.5%
20232023-12-31USD 2,011,518,000-13.3%
Endo International Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32021-09-308.2%
Q42021-12-312.3%
Q12022-03-31-17.4%
Q22022-06-30-12.7%
Endo International Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -2.63N/A
20222022-12-31USD -12.45372.5%
20232023-12-31USD -10.42-16.3%
Endo International Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32021-09-30-397.0%
Q42021-12-31-621.2%
Q12022-03-3188.2%
Q22022-06-30-2764.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2022YOY CHG

Revenue

$569.11M

-20.3%

Gross Profit

$305.33M

-22.8%

Gross Margin

53.65%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

3,103

N/A

Net Income

-$1.89B

-12064.0%

EBITDA

-$1.88B

-513.4%

Quarterly Fundamentals

Name
Q2 2022YOY CHG

Total Cash

$1.19B

-22.9%

Total Debt

$8.11B

-2.6%

Accounts Receivable

$491.49M

+7.3%

Inventory

$287.76M

-15.0%

Long Term Debt

$8.07B

-0.2%

Short Term Debt

$36.99M

-84.3%

Return on Assets

-6.49%

N/A

Return on Invested Capital

0.22%

N/A

Free Cash Flow

$153.77M

-32.3%

Operating Cash Flow

$201.32M

-17.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZYNEZynerba Pharmaceuticals, Inc.
$1.30+2.36%
LIENChicago Atlantic BDC, Inc.
$9.41-1.26%
DRRXDURECT Corporation
$1.91-1.04%
NAKANakamoto Inc.
$4.97+2.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
NOKNokia
$9.73-0.05%
SMCISuper Micro Computer
$31.20+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$66.30-0.06%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.